IP
AVNS

Isthmus Partners’s Avanos Medical AVNS Stock Holding History

Isthmus Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,200
Closed -$54K – 296
2017
Q3 		$54K Buy
+1,200
New +$51.2K 0.02% 168
2015
Q4 		– Sell
-62
Closed -$2K – 260
2015
Q3 		$2K Hold
62
– – ﹤0.01% 267
2015
Q2 		$3K Sell
62
-57
-48% -$2.56K ﹤0.01% 262
2015
Q1 		$6K Sell
119
-6,599
-98% -$306K ﹤0.01% 250
2014
Q4 		$305K Buy
+6,718
New +$264K 0.1% 115

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Isthmus Partners's AVNS Position: Q4 2017 in Review

Isthmus Partners sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 1,200 shares — an estimated $54K sold.

Isthmus Partners first reported a position in AVNS in Q4 2014 and held it in 5 quarters. The position peaked at $305K in Q4 2014. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Isthmus Partners reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
  • Isthmus Partners sold 1,200 Avanos Medical shares in Q4 2017, an estimated $54K.
  • Isthmus Partners first reported a position in Avanos Medical in Q4 2014 and held it in 5 quarters.
  • Isthmus Partners's Avanos Medical position peaked at $305K in Q4 2014.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Isthmus Partners's 13F filing for Q4 2017, filed 5 Feb 2018.